Beta Bionics, Inc.
Develops an automated insulin delivery system to simplify management of type 1 diabetes.
BBNX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11 HUGHES, 92618 IRVINE
- Website:
- https://www.betabionics.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to simplifying diabetes management. The company develops and markets the iLet Bionic Pancreas, an FDA-cleared automated insulin delivery (AID) system. The iLet uses an adaptive algorithm to learn a user's insulin needs from data provided by a compatible continuous glucose monitor (CGM), such as the Dexcom G7 or Abbott FreeStyle Libre 3. It then autonomously determines and delivers 100% of the required insulin doses, aiming to reduce the cognitive burden on individuals with type 1 diabetes by minimizing the need for manual carb counting and dose corrections.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Beta Bionics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Beta Bionics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beta Bionics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
